Skip to main content
. 2021 Apr 1;11:7362. doi: 10.1038/s41598-021-86826-7

Table 3.

Adverse events in both groups.

Opioid-based group Opioid-sparing group P values
(N = 28) (N = 28)
Adverse events
Nausea and vomiting 2 (7.1%) 2 (7.1%) 1
Dry mouth 0 0
Dizziness 2 (7.1%) 1 (3.6%) 0.55
Pruritus or skin rash 3(10.7%) 0 0.24
Constipation 2 (7.1%) 2 (7.1%) 1
Dyspepsia or gastrointestinal bleeding 0 0
Cardiovascular events 0 0
Urinary retention 0 0
Respiratory depression 0 0
Sedation or cognitive impairment 1 (3.6%) 0 1
Total events 10 5 0.26